FDA Releases New Draft Guidance on DSCSA Tracking Standards, Definitions

Drug GMP Report
A A
The FDA issued two draft guidances aimed at implementing the Drug Supply Chain Security Act’s provisions for an electronic track-and-trace system for certain prescription drugs extending throughout the supply chain — one recommending data and documentation practices and another defining terms such as “suspect products” and “illegitimate products.”

To View This Article:

Login

Subscribe To Drug GMP Report